Startseite Medizin Influence of pneumatic tube system transport on routinely assessed and spectrophotometric cerebrospinal fluid parameters
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Influence of pneumatic tube system transport on routinely assessed and spectrophotometric cerebrospinal fluid parameters

  • Pavel Broz EMAIL logo , Daniel Rajdl , Jaroslav Racek , Jana Zenkova und Vlasta Petrikova
Veröffentlicht/Copyright: 30. Juni 2016
Clinical Chemistry and Laboratory Medicine (CCLM)
Aus der Zeitschrift Clinical Chemistry and Laboratory Medicine (CCLM) Band 55 Heft 1

Abstract

Background:

Pneumatic tube systems (PTS) are widely used in many hospitals. Using PTS reduces turnaround time (TAT) and can improve patients’ outcome.

Methods:

We investigated whether clinically significant differences could be observed in CSF samples transported by pneumatic tube in comparison with samples transported by hand. Two aliquots from one sample were sent by PTS and by hand from the department of neurology or neurosurgery and compared.

Results:

Routine cytological and biochemical assessment was compared in 27 cases. There were no statistically significant changes (transport by hand vs. PTS) in glucose levels [data are expressed as median (minimum–maximum)] at 3.7 (2.5–8.6) mmol/L vs. 3.6 (2.7–8.6) mmol/L, p=0.96 or lactate levels at 1.8 mmol/L (1.1–5.5) vs. 1.8 mmol/L (1.1–5.4). We observed a statistically significant decline in total protein levels in samples transported by PTS at 0.56 g/L (0.19–4.29) vs. 0.49 g/L (0.18–4.3), p=0.008. We observed no changes in erythrocyte count at 5/μL (0–40,000) vs. 5/μL (0–40,106), mononuclear cells at 2/μL (1–145) vs. 3/μL (1–152), or polynuclear cells at 0/μL (0–235) vs. 0/μL (0–352). Spectrophotometric examination was performed in 20 cases. There were no statistically significant differences (transport by hand vs. transport by PTS) in NOA at 0.002 (0.001–1.537) vs. 0.001 (0.001–1.528), p=0.95 or NBA at 0.001 (0.001–0.231) vs. 0.001 (0.001–0.276), p=0.675. Samples transported by PTS were delivered faster than samples transported by courier (transport by hand vs. PTS) at 25 min (10–153) vs. 15 min (4–110), p=0.002.

Conclusions:

We found no significant changes in glucose, lactate levels and in any of the cytological parameters assessed, nor were statistically significant changes observed in the spectrophotometric parameters. We found a statistically significant decrease in total protein levels in samples transported by PTS. Transport by PTS can be faster than transport by hand.

Keywords: cerebrospinal fluid; cytology; pneumatic tube; spectrophotometry

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: The study was supported by the Ministry of Health, Czech Republic – Conceptual Development of Research Organisation (FNPl – 00669806).

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organisation(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Fernandes CM, Worster A, Eva K, Hill S, McCallum C. Pneumatic tube delivery system for blood samples reduces turnaround times without affecting sample quality. J Emerg Nurs 2006;32:139–43.10.1016/j.jen.2005.11.013Suche in Google Scholar

2. Guss DA, Chan TC, Killeen JP. The impact of a pneumatic tube and computerized physician order management on laboratory turnaround time. Ann Emerg Med 2008;51:181–5.10.1016/j.annemergmed.2007.03.010Suche in Google Scholar

3. Fernandes CM, Walker R, Pricern A, Marsden J, Haley L. Root cause analysis of laboratory delays to an emergency department. J Emerg Med 1997;15:735–9.10.1016/S0736-4679(97)00158-3Suche in Google Scholar

4. Hawkins RC. Laboratory turnaround time. Clin Biochem Rev 2007;28:179–94.Suche in Google Scholar

5. Kara H, Bayir A, Ak A, Degirmenci S, Akinci M, Agacayak A, et al. Hemolysis associated with pneumatic tube system transport for blood samples. Pak J Med Sci 2014;30:50–8.10.12669/pjms.301.4228Suche in Google Scholar

6. Stair TO, Howell JM, Fitzgerald DJ, Bailey SC, Bastasch MD. Hemolysis of blood specimens transported from ED to laboratory by pneumatic tube. Am J Emerg Med 1995;13:484.10.1016/0735-6757(95)90145-0Suche in Google Scholar

7. Keshgegian AA, Bull GE. Evaluation of a soft-handling computerized pneumatic tube specimen delivery system. Effects on analytical results and turnaround time. Am J Clin Pathol 1992;97:535–40.10.1093/ajcp/97.4.535Suche in Google Scholar

8. Zaman Z, Demedts M. Blood gas analysis: POCT versus central laboratory on samples sent by a pneumatic tube system. Clin Chim Acta 2001;307:101–6.10.1016/S0009-8981(01)00439-9Suche in Google Scholar

9. Victor Peter J, Patole S, Fleming JJ, Selvakumar R, Graham PL. Agreement between paired blood gas values in samples transported either by a pneumatic system or by human courier. Clin Chem Lab Med 2011;49:1303–9.10.1515/CCLM.2011.611Suche in Google Scholar PubMed

10. Lu JY, Kao JT, Chien TI, Lee TF, Tsai KS. Effects of air bubbles and tube transportation on blood oxygen tension in arterial blood gas analysis. J Formos Med Assoc Taiwan Yi Zhi 2003;102:246–9.Suche in Google Scholar

11. Transport von Blutgasproben – Springer. [cited 2014 Sep 3]; Available from: http://link.springer.com/article/10.1007/s00101-006-1069-5/fulltext.html.Suche in Google Scholar

12. Collinson PO, John CM, Gaze DC, Ferrigan LF, Cramp DG. Changes in blood gas samples produced by a pneumatic tube system. J Clin Pathol 2002;55:105–7.10.1136/jcp.55.2.105Suche in Google Scholar PubMed PubMed Central

13. Evliyaoğlu O, Toprak G, Tekin A, Başarali MK, Kilinç C, Colpan L. Effect of pneumatic tube delivery system rate and distance on hemolysis of blood specimens. J Clin Lab Anal 2012;26: 66–9.10.1002/jcla.21484Suche in Google Scholar PubMed PubMed Central

14. Kratz A, Salem RO, Van Cott EM. Effects of a pneumatic tube system on routine and novel hematology and coagulation parameters in healthy volunteers. Arch Pathol Lab Med 2007;131:293–6.10.5858/2007-131-293-EOAPTSSuche in Google Scholar PubMed

15. Amann G, Zehntner C, Marti F, Colucci G. Effect of acceleration forces during transport through a pneumatic tube system on ROTEM® analysis. Clin Chem Lab Med 2012;50:1335–42.10.1515/cclm-2011-0800Suche in Google Scholar PubMed

16. Hübner U, Böckel-Frohnhöfer N, Hummel B, Geisel J. The effect of a pneumatic tube transport system on platelet aggregation using optical aggregometry and the PFA-100. Clin Lab 2010;56:59–64.Suche in Google Scholar

17. Lancé MD, Marcus MA, van Oerle R, Theunissen HM, Henskens YM. Platelet concentrate transport in pneumatic tube systems – does it work? Vox Sang 2012;103:79–82.10.1111/j.1423-0410.2011.01580.xSuche in Google Scholar PubMed

18. Wenham PR, Hanson T, Ashby JP. Interference in spectrophotometric analysis of cerebrospinal fluid by haemolysis induced by transport through a pneumatic tube system. Ann Clin Biochem 2001;38(Pt 4):371–5.10.1258/0004563011900687Suche in Google Scholar PubMed

19. Jones L, Isbister G, Chesher D, Gillett M. Pneumatic tube transport of blood-stained cerebrospinal fluid specimens has no clinically relevant effect on rates of haemolysis compared to manual transport. Ann Clin Biochem 2016;53(Pt 1):168–73.10.1177/0004563215593562Suche in Google Scholar PubMed

20. Thomas L. Clinical laboratory diagnostics: use and assessment of clinical laboratory results. Frankfurt, Germany: TH-Books, 1998.Suche in Google Scholar

21. Gomes HR, Gomes HR. Cerebrospinal fluid approach on neuro-oncology. Arq Neuropsiquiatr 2013;71:677–80.10.1590/0004-282X20130149Suche in Google Scholar PubMed

22. Deisenhammer F, Bartos A, Egg R, Gilhus NE, Giovannoni G, Rauer S, et al. Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur J Neurol 2006;13:913–22.10.1111/j.1468-1331.2006.01493.xSuche in Google Scholar PubMed

23. Jurado R, Walker HK. Cerebrospinal Fluid. In: Walker HK, Hall WD, Hurst JW, editors. Clinical methods: the history, physical, and laboratory examinations [Internet]. 3rd ed. Boston: Butterworths, 1990 [cited 2014 Mar 7]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK398/.Suche in Google Scholar

24. Cruickshank A, Auld P, Beetham R, Burrows G, Egner W, Holbrook I, et al. Revised national guidelines for analysis of cerebrospinal fluid for bilirubin in suspected subarachnoid haemorrhage. Ann Clin Biochem 2008;45(Pt 3):238–44.10.1258/acb.2008.007257Suche in Google Scholar PubMed

25. Beetham R, Fahie-Wilson MN, Holbrook I, Thomas P, Ward AM, Watson ID, et al. CSF spectrophotometry in the diagnosis of subarachnoid haemorrhage. J Clin Pathol 2002;55:479–80.10.1136/jcp.55.6.479Suche in Google Scholar PubMed PubMed Central

26. Chalmers AH. Cerebrospinal fluid xanthochromia testing simplified. Clin Chem 2001;47:147–8.10.1093/clinchem/47.1.147Suche in Google Scholar

27. Ellis G. An episode of increased hemolysis due to a defective pneumatic air tube delivery system. Clin Biochem 2009;42:1265–9.10.1016/j.clinbiochem.2009.05.002Suche in Google Scholar PubMed

Received: 2016-2-23
Accepted: 2016-5-27
Published Online: 2016-6-30
Published in Print: 2017-1-1

©2017 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. Describing children’s changes using clinical chemistry analytes
  4. Review
  5. Assessment of vitamin D status – a changing landscape
  6. Opinion Papers
  7. Order of blood draw: Opinion Paper by the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)
  8. The principles of Health Technology Assessment in laboratory medicine
  9. Genetics and Molecular Diagnostics
  10. Functional polymorphism of lncRNA MALAT1 contributes to pulmonary arterial hypertension susceptibility in Chinese people
  11. General Clinical Chemistry and Laboratory Medicine
  12. Influence of pneumatic tube system transport on routinely assessed and spectrophotometric cerebrospinal fluid parameters
  13. Estimation of hematocrit in filter paper dried bloodspots by potassium measurement: advantage of use of perimeter ring samples over circular center sub-punch samples
  14. Evaluation of the first fully automated immunoassay method for the measurement of stimulating TSH receptor autoantibodies in Graves’ disease
  15. Comparison of four immunoassays to measure serum ferritin concentrations and iron deficiency prevalence among non-pregnant Cambodian women and Congolese children
  16. Activity and expression of dipeptidyl peptidase IV on peripheral blood mononuclear cells in patients with early steroid and disease modifying antirheumatic drugs naïve rheumatoid arthritis
  17. Hematology and Coagulation
  18. Neutrophil CD64 Index as a superior biomarker for early diagnosis of infection in febrile patients in the hematology department
  19. Dilute Russell’s viper venom time reagents in lupus anticoagulant testing: a well-considered choice
  20. Reference Values and Biological Variations
  21. Pediatric reference intervals for alkaline phosphatase
  22. Cancer Diagnostics
  23. Transcript expression and genetic variability analysis of caspases in breast carcinomas suggests CASP9 as the most interesting target
  24. CDH1 (E-cadherin) expression independently affects clinical outcome in acute myeloid leukemia with normal cytogenetics
  25. Cardiovascular Diseases
  26. Association of monocyte to HDL cholesterol level with contrast induced nephropathy in STEMI patients treated with primary PCI
  27. Low concentrations of adropin are associated with endothelial dysfunction as assessed by flow-mediated dilatation in patients with metabolic syndrome
  28. Preoperative serum potassium predicts the clinical outcome after non-cardiac surgery
  29. Diabetes
  30. A simple colorimetric assay for measuring fructosamine 3 kinase activity
  31. Acknowledgment
  32. Acknowledgment
  33. Letters to the Editor
  34. Normalisation issues in glucose measurements using phlebotomy tubes with liquid additives
  35. Utility of dilution tests in investigating interference in the free thyroxine assay
  36. Plasminogen activator inhibitor-1 as a marker of cardiovascular response in professional mountain ultra-marathon runners
  37. Pitfalls of LSD screening assays: comparison of KIMS and CEDIA immunoassays with LC-MS
  38. A two site comparison of two point-of-care activated clotting time systems
  39. Detection of the common South-East Asian β0-thalassemia mutations in samples with borderline HbA2 levels
  40. Biclonal plasma cell myeloma with the simultaneous appearance of both secretory lambda and nonsecretory kappa monoclonal light chains
https://doi.org/10.1515/cclm-2016-0143
Schlagwörter für diesen Artikel
cerebrospinal fluid; cytology; pneumatic tube; spectrophotometry

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. Describing children’s changes using clinical chemistry analytes
  4. Review
  5. Assessment of vitamin D status – a changing landscape
  6. Opinion Papers
  7. Order of blood draw: Opinion Paper by the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)
  8. The principles of Health Technology Assessment in laboratory medicine
  9. Genetics and Molecular Diagnostics
  10. Functional polymorphism of lncRNA MALAT1 contributes to pulmonary arterial hypertension susceptibility in Chinese people
  11. General Clinical Chemistry and Laboratory Medicine
  12. Influence of pneumatic tube system transport on routinely assessed and spectrophotometric cerebrospinal fluid parameters
  13. Estimation of hematocrit in filter paper dried bloodspots by potassium measurement: advantage of use of perimeter ring samples over circular center sub-punch samples
  14. Evaluation of the first fully automated immunoassay method for the measurement of stimulating TSH receptor autoantibodies in Graves’ disease
  15. Comparison of four immunoassays to measure serum ferritin concentrations and iron deficiency prevalence among non-pregnant Cambodian women and Congolese children
  16. Activity and expression of dipeptidyl peptidase IV on peripheral blood mononuclear cells in patients with early steroid and disease modifying antirheumatic drugs naïve rheumatoid arthritis
  17. Hematology and Coagulation
  18. Neutrophil CD64 Index as a superior biomarker for early diagnosis of infection in febrile patients in the hematology department
  19. Dilute Russell’s viper venom time reagents in lupus anticoagulant testing: a well-considered choice
  20. Reference Values and Biological Variations
  21. Pediatric reference intervals for alkaline phosphatase
  22. Cancer Diagnostics
  23. Transcript expression and genetic variability analysis of caspases in breast carcinomas suggests CASP9 as the most interesting target
  24. CDH1 (E-cadherin) expression independently affects clinical outcome in acute myeloid leukemia with normal cytogenetics
  25. Cardiovascular Diseases
  26. Association of monocyte to HDL cholesterol level with contrast induced nephropathy in STEMI patients treated with primary PCI
  27. Low concentrations of adropin are associated with endothelial dysfunction as assessed by flow-mediated dilatation in patients with metabolic syndrome
  28. Preoperative serum potassium predicts the clinical outcome after non-cardiac surgery
  29. Diabetes
  30. A simple colorimetric assay for measuring fructosamine 3 kinase activity
  31. Acknowledgment
  32. Acknowledgment
  33. Letters to the Editor
  34. Normalisation issues in glucose measurements using phlebotomy tubes with liquid additives
  35. Utility of dilution tests in investigating interference in the free thyroxine assay
  36. Plasminogen activator inhibitor-1 as a marker of cardiovascular response in professional mountain ultra-marathon runners
  37. Pitfalls of LSD screening assays: comparison of KIMS and CEDIA immunoassays with LC-MS
  38. A two site comparison of two point-of-care activated clotting time systems
  39. Detection of the common South-East Asian β0-thalassemia mutations in samples with borderline HbA2 levels
  40. Biclonal plasma cell myeloma with the simultaneous appearance of both secretory lambda and nonsecretory kappa monoclonal light chains
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2026 De Gruyter Brill
Heruntergeladen am 1.3.2026 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2016-0143/html
Button zum nach oben scrollen